查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1824362

2025年綜合代謝組（CMP）檢測全球市場報告

Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年，綜合代謝組 (CMP) 檢測市場規模將強勁成長，到 2029 年將達到 259.5 億美元，複合年成長率為 9.1%。預測期內的成長歸因於個人化和精準醫療、CMP 檢測與遠端醫療服務的整合、對全面健康體檢的需求、日益增多的健康和預防保健舉措，以及不斷發展的醫療保健政策和政策。預測期內的主要趨勢包括持續監測和縱向追蹤、適合遠端醫療的報告格式、參考範圍的標準化、穿戴式健康技術的整合以及對病患​​教育和參與的重視。

今後5年間の成長率9.1％という予測は、前回予測から0.2％の微減を反映しています。この減少は主に美國と他国との間の関税の影響によるものです。関税の高騰は、日本やアイルランドから調達する自動化学分析装置や電解質検査試薬のコストを押し上げ、ルーチンの篩檢コストを悪化させ、重症加護の結果を遅らせることで、美國の検査施設に負担をかける可能性が高いです。また、相互関税や、貿易緊張の高まりと制限による世界経済と貿易への悪影響により、その影響はより広範囲に及ぶと思われます。

心血管疾病和糖尿病盛行率的預期成長預計將推動綜合代謝組 (CMP) 檢測市場的成長。影響心臟和血管的心血管疾病通常與動脈粥狀硬化（動脈中脂肪沉積的堆積）有關。同時，以血糖值升高為特徵的糖尿病可以透過綜合METABOLIC INC.組 (CMP) 血液檢查來識別。隨著糖尿病和心血管疾病病例的增加，對包括 CMP 血液檢查在內的診斷性血液檢查的需求預計將激增。例如，澳洲健康與福利研究所提供的 2023 年 12 月數據顯示，醫生認證的因心臟疾病(CHD) 死亡的人數呈上升趨勢，到 2022 年將達到 14,900 人。此外，2022 年 6 月，國際糖尿病聯盟報告稱，全球糖尿病盛行率為 10.5%，其中相當一部分人 (44.7%) 未得到診斷。因此，心血管疾病和糖尿病的盛行率不斷上升是推動綜合代謝組 (CMP) 檢測市場發展的主要因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球綜合代謝組 (CMP) 測試：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球綜合代謝組（CMP）檢測市場：成長率分析
  • 全球綜合代謝組 (CMP) 檢測市場表現：規模與成長，2019-2024 年
  • 全球綜合代謝組 (CMP) 檢測市場預測：規模與成長，2024-2029 年，2034 年
  • 全球綜合代謝組 (CMP) 測試：總目標市場 (TAM)

第6章 市場細分

  • 全球綜合代謝組 (CMP) 檢測市場：按疾病、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 腎臟疾病
  • 肝病
  • 糖尿病
  • 其他疾病
  • 全球綜合代謝組 (CMP) 檢測市場（按檢測類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 蛋白質
  • 電解質
  • 腎臟檢查
  • 肝功能檢查
  • 葡萄糖
  • 全球綜合代謝組 (CMP) 檢測市場：按最終用戶、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 研究所
  • 照護現場（PoC）
  • 全球綜合代謝組 (CMP) 檢測市場：按腎臟疾病類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 慢性腎臟病（CKD）
  • 急性腎損傷（AKI）
  • 腎絲球腎炎
  • 全球綜合代謝組 (CMP) 檢測市場：依肝病類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 肝炎（病毒性和非病毒性）
  • 肝硬化
  • 脂肪肝
  • 全球綜合代謝組 (CMP) 檢測市場：按糖尿病類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 1型糖尿病
  • 2型糖尿病
  • 妊娠糖尿病
  • 全球綜合代謝組 (CMP) 檢測市場：按疾病類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 心血管疾病
  • 電解質失衡
  • 代謝紊亂
  • 胰臟疾病

第7章 區域和國家分析

  • 全球綜合代謝組 (CMP) 檢測市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球綜合代謝組 (CMP) 檢測市場：按國家/地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 綜合代謝組（CMP）檢測市場：競爭格局
  • 綜合代謝組（CMP）檢測市場：公司簡介
    • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • Mercy Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Mount Sinai Health System
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • Hologic Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Werfen SA
  • DiaSorin SpA
  • Randox Laboratories Ltd.
  • ARUP Laboratories Inc.
  • Invitae Corporation
  • Abaxis Inc.
  • Metropolis Healthcare Limited
  • Clinical Reference Laboratory（CRL）
  • Centogene AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年綜合代謝組（CMP）檢測市場：提供新機會的國家
  • 2029年綜合代謝組（CMP）檢測市場：細分市場帶來新機會
  • 2029年綜合代謝組（CMP）檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24818u

A comprehensive metabolic panel (CMP) test is a blood analysis consisting of 14 distinct parameters that provide crucial insights into the body's chemical balance and metabolic processes. This test serves as a vital tool for evaluating nutritional levels, liver and kidney functionality, and aids in diagnosing, screening, and monitoring various health conditions.

The primary diseases and health conditions assessed through comprehensive metabolic panel (CMP) testing include kidney disease, liver disease, diabetes, and other metabolic disorders. Kidney disease is characterized by impaired kidney function, affecting its ability to effectively filter blood and perform essential functions. The test encompasses evaluations of proteins, electrolytes, kidney function, liver function, and glucose levels, conducted in both laboratory settings and point-of-care (PoC) environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The comprehensive metabolic panel (CMP) testing market research report is one of a series of new reports from The Business Research Company that provides comprehensive metabolic panel (CMP) testing market statistics, including comprehensive metabolic panel (CMP) testing industry global market size, regional shares, competitors with a comprehensive metabolic panel (CMP) testing market share, detailed comprehensive metabolic panel (CMP) testing market segments, market trends and opportunities, and any further data you may need to thrive in the comprehensive metabolic panel (CMP) testing industry. This comprehensive metabolic panel (CMP) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The comprehensive metabolic panel (cmp) testing market size has grown strongly in recent years. It will grow from $17.04 billion in 2024 to $18.34 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to a rise in chronic diseases, demand for holistic health assessments, healthcare system emphasis on preventive care, rise in lifestyle-related conditions, and patient-centric healthcare approach.

The comprehensive metabolic panel (cmp) testing market size is expected to see strong growth in the next few years. It will grow to $25.95 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to personalized medicine and precision healthcare, integration of CMP testing in telehealth services, demand for comprehensive health screenings, rise in wellness and preventive health initiatives, and evolving healthcare policies and regulations. Major trends in the forecast period include continuous monitoring and longitudinal tracking, telemedicine-friendly reporting formats, standardization of reference ranges, integration of wearable health technology, and emphasis on patient education and engagement.

The forecast of 9.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. laboratories by driving up the cost of automated chemistry analyzers and electrolyte testing reagents sourced from Japan and Ireland, exacerbating routine screening costs and delaying critical care results. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the prevalence of cardiovascular diseases and diabetes is expected to be a driving force behind the growth of the comprehensive metabolic panel (CMP) testing market. Cardiovascular diseases, which affect the heart and blood vessels, are often associated with atherosclerosis-the accumulation of fatty deposits within arteries. Concurrently, diabetes, characterized by elevated blood glucose levels, can be identified through comprehensive metabolic panel (CMP) blood tests. As cases of diabetes and cardiovascular diseases increase, the demand for diagnostic blood tests, including the CMP blood test, is likely to surge. For instance, data from December 2023 provided by the Australian Institute of Health and Welfare indicated a rising trend in doctor-certified fatalities attributed to coronary heart disease (CHD), reaching 14,900 in 2022. Additionally, in June 2022, the International Diabetes Federation reported a global diabetes prevalence of 10.5%, with a significant portion (44.7%) of individuals remaining undiagnosed. Consequently, the growing incidence of cardiovascular diseases and diabetes is a key driver propelling the comprehensive metabolic panel (CMP) testing market.

The growing geriatric population is expected to drive the expansion of the comprehensive metabolic panel (CMP) testing market in the coming years. The term "geriatric population" refers to individuals who are elderly, typically defined as those aged 65 or older. Due to their advanced age, older individuals generally require more frequent health screenings, including metabolic panel testing, to monitor their well-being and address age-related issues. CMP testing is essential for the elderly, helping to detect underlying conditions like kidney disease, hormonal imbalances, and diabetes. For instance, in July 2024, according to the UK Parliament, a UK-based governing body, 12.7 million people in the UK were aged 65 or older in 2022 (accounting for 19% of the population), and by 2072, this figure is projected to increase to 22.1 million, or 27% of the population. Thus, the rising geriatric population is fueling the growth of the CMP testing market.

The comprehensive metabolic panel (CMP) testing market is witnessing a significant trend of technological advancements, with major companies investing in innovative solutions to fortify their market positions. In April 2022, HealthifyMe, an Indian wellness and fitness services company, introduced HealthifyPro, a flagship fitness plan incorporating a metabolic panel based on a comprehensive blood test measuring over 80 different factors. HealthifyPro utilizes a biosensor system, a smart scale, health coaches, an AI assistant, and a metabolic panel to track users' health. The integration of glucose patterns, dietary habits, and exercise behaviors enables the creation of personalized health approaches for each user, showcasing the role of technology in advancing metabolic panel testing.

Strategic partnerships are a prominent approach adopted by major companies in the comprehensive metabolic panel (CMP) testing market. These partnerships aim to enhance production capabilities, streamline testing processes, and meet the increasing demand for CMP testing across various industries. In August 2022, Abbott Laboratories, a US-based healthcare company, collaborated with WW International Inc., a provider of weight loss and fitness services. The partnership focuses on assisting individuals with diabetes in better understanding and managing their health. By integrating WeightWatchers' diabetes-specific weight management program with Abbott's FreeStyle Libre offerings, the collaboration aims to provide a seamless mobile experience, offering valuable insights for individuals with diabetes to make informed dietary adjustments and improve blood sugar levels, ultimately empowering them to take control of their health.

In March 2023, Fluxery, a medical diagnostic company headquartered in the United States, completed the acquisition of particular personnel, assets, and licensed electrochemical biosensing technologies from InnaMed Inc. The financial details of the transaction remain undisclosed. This strategic acquisition by Fluxery significantly expands its detection capabilities, allowing for the analysis of clinical chemistry and small molecules in various domains, including human healthcare, equine care, and veterinary services for small animals. InnaMed Inc., a decentralized blood testing company in the US, specializes in electrochemical biosensor technology.

Major companies operating in the comprehensive metabolic panel (CMP) testing market include Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC

North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (cmp) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the comprehensive metabolic panel (cmp) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The comprehensive metabolic panel (CMP) testing market includes revenues earned by entities by providing glucose tests, sodium tests, and albumin tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on comprehensive metabolic panel (cmp) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for comprehensive metabolic panel (cmp) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The comprehensive metabolic panel (cmp) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease: Kidney Disease; Liver Disease; Diabetes; Other Diseases
  • 2) By Test Type: Proteins; Electrolytes; Kidney Tests; Liver Functional Tests; Glucose
  • 3) By End User: Laboratories; Point Of Care (PoC)
  • Subsegments:
  • 1) By Kidney Disease: Chronic Kidney Disease (CKD); Acute Kidney Injury (AKI); Glomerulonephritis
  • 2) By Liver Disease: Hepatitis (Viral And Non-Viral); Cirrhosis; Fatty Liver Disease
  • 3) By Diabetes: Type 1 Diabetes; Type 2 Diabetes; Gestational Diabetes
  • 4) By Other Diseases: Cardiovascular Diseases; Electrolyte Imbalances; Metabolic Disorders; Pancreatic Diseases
  • Companies Mentioned: Abbott Laboratories Inc.; Siemens Healthineers AG; Mayo Clinic; Laboratory Corporation of America Holdings; Mercy; Mount Sinai Health System; Quest Diagnostics Incorporated; Sonic Healthcare Limited; Hologic Inc.; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Werfen SA; DiaSorin S.p.A.; Randox Laboratories Ltd.; ARUP Laboratories Inc.; Invitae Corporation; Abaxis Inc.; Metropolis Healthcare Limited; Clinical Reference Laboratory (CRL); Centogene AG; Spectra Laboratories; Unipath Systems Ltd.; Scion Lab Services LLC; Weldon Biotech Pvt Ltd.; Corona Pathology;Ulta Lab Tests LLC; Any Lab Test Now; Applied InGENuity Diagnostics LLC; Walk-In Lab LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Comprehensive Metabolic Panel (CMP) Testing Market Characteristics

3. Comprehensive Metabolic Panel (CMP) Testing Market Trends And Strategies

4. Comprehensive Metabolic Panel (CMP) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Comprehensive Metabolic Panel (CMP) Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Comprehensive Metabolic Panel (CMP) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Comprehensive Metabolic Panel (CMP) Testing Market Growth Rate Analysis
  • 5.4. Global Comprehensive Metabolic Panel (CMP) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Comprehensive Metabolic Panel (CMP) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Comprehensive Metabolic Panel (CMP) Testing Total Addressable Market (TAM)

6. Comprehensive Metabolic Panel (CMP) Testing Market Segmentation

  • 6.1. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Disease
  • Liver Disease
  • Diabetes
  • Other Diseases
  • 6.2. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proteins
  • Electrolytes
  • Kidney Tests
  • Liver Functional Tests
  • Glucose
  • 6.3. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratories
  • Point Of Care (PoC)
  • 6.4. Global Comprehensive Metabolic Panel (CMP) Testing Market, Sub-Segmentation Of Kidney Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chronic Kidney Disease (CKD)
  • Acute Kidney Injury (AKI)
  • Glomerulonephritis
  • 6.5. Global Comprehensive Metabolic Panel (CMP) Testing Market, Sub-Segmentation Of Liver Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatitis (Viral And Non-Viral)
  • Cirrhosis
  • Fatty Liver Disease
  • 6.6. Global Comprehensive Metabolic Panel (CMP) Testing Market, Sub-Segmentation Of Diabetes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
  • 6.7. Global Comprehensive Metabolic Panel (CMP) Testing Market, Sub-Segmentation Of Other Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Diseases
  • Electrolyte Imbalances
  • Metabolic Disorders
  • Pancreatic Diseases

7. Comprehensive Metabolic Panel (CMP) Testing Market Regional And Country Analysis

  • 7.1. Global Comprehensive Metabolic Panel (CMP) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Comprehensive Metabolic Panel (CMP) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market

  • 8.1. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Comprehensive Metabolic Panel (CMP) Testing Market

  • 9.1. China Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 9.2. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Comprehensive Metabolic Panel (CMP) Testing Market

  • 10.1. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Comprehensive Metabolic Panel (CMP) Testing Market

  • 11.1. Japan Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 11.2. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Comprehensive Metabolic Panel (CMP) Testing Market

  • 12.1. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market

  • 13.1. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Comprehensive Metabolic Panel (CMP) Testing Market

  • 14.1. South Korea Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 14.2. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market

  • 15.1. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 15.2. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Comprehensive Metabolic Panel (CMP) Testing Market

  • 16.1. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Comprehensive Metabolic Panel (CMP) Testing Market

  • 17.1. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Comprehensive Metabolic Panel (CMP) Testing Market

  • 18.1. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Comprehensive Metabolic Panel (CMP) Testing Market

  • 19.1. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Comprehensive Metabolic Panel (CMP) Testing Market

  • 20.1. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market

  • 21.1. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 21.2. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Comprehensive Metabolic Panel (CMP) Testing Market

  • 22.1. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Comprehensive Metabolic Panel (CMP) Testing Market

  • 23.1. North America Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 23.2. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Comprehensive Metabolic Panel (CMP) Testing Market

  • 24.1. USA Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 24.2. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Comprehensive Metabolic Panel (CMP) Testing Market

  • 25.1. Canada Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 25.2. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Comprehensive Metabolic Panel (CMP) Testing Market

  • 26.1. South America Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 26.2. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Comprehensive Metabolic Panel (CMP) Testing Market

  • 27.1. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Comprehensive Metabolic Panel (CMP) Testing Market

  • 28.1. Middle East Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 28.2. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Comprehensive Metabolic Panel (CMP) Testing Market

  • 29.1. Africa Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 29.2. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Comprehensive Metabolic Panel (CMP) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Comprehensive Metabolic Panel (CMP) Testing Market Competitive Landscape
  • 30.2. Comprehensive Metabolic Panel (CMP) Testing Market Company Profiles
    • 30.2.1. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Mercy Overview, Products and Services, Strategy and Financial Analysis

31. Comprehensive Metabolic Panel (CMP) Testing Market Other Major And Innovative Companies

  • 31.1. Mount Sinai Health System
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Sonic Healthcare Limited
  • 31.4. Hologic Inc.
  • 31.5. Beckman Coulter Inc.
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. Werfen SA
  • 31.8. DiaSorin S.p.A.
  • 31.9. Randox Laboratories Ltd.
  • 31.10. ARUP Laboratories Inc.
  • 31.11. Invitae Corporation
  • 31.12. Abaxis Inc.
  • 31.13. Metropolis Healthcare Limited
  • 31.14. Clinical Reference Laboratory (CRL)
  • 31.15. Centogene AG

32. Global Comprehensive Metabolic Panel (CMP) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Comprehensive Metabolic Panel (CMP) Testing Market

34. Recent Developments In The Comprehensive Metabolic Panel (CMP) Testing Market

35. Comprehensive Metabolic Panel (CMP) Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Comprehensive Metabolic Panel (CMP) Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Comprehensive Metabolic Panel (CMP) Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Comprehensive Metabolic Panel (CMP) Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer